0 items USD 0.00Search
Your search for "Pharma" gave back 126 results.
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
颁补迟补濒辞驳:听
La Merie Publishing
June 2019
Price: USD 2,700.00
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research鈥檚 latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability, and stability of active...
IQ4I
July 2019
Price: USD 4,950.00
Cadherins are a family of glycoproteins responsible for calcium ion鈥揹ependent cell adhesion. There are more than 100 types of cadherins in humans,...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 450.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
颁补迟补濒辞驳:听
La Merie Publishing
March 2015
Price: USD 2,183.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
颁补迟补濒辞驳:听
La Merie Publishing
May 2020
Price: USD 2,350.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 560.00
This report evaluates G-protein鈥揷oupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 670.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
颁补迟补濒辞驳:听
La Merie Publishing
February 2023
Price: USD 2,000.00
Contract Research Organization 麻豆原创 Global Deals and Operational Strategies discusses the deal making activity during the past five years and in-...
颁补迟补濒辞驳:听
CBR Pharma Insights
June 2015
Price: USD 2,995.00
The report 鈥淎ntibody Technologies and Attrition Rates 鈥� an industry analysis 2013鈥� is based on the identification of the antibody generation...
颁补迟补濒辞驳:听
La Merie Publishing
March 2013
Price: USD 2,960.00
How do antibody characteristics impact clinical success? The analytical report 鈥濱nfluence of Antibody Attributes on Clinical Success 鈥� A Technology...
颁补迟补濒辞驳:听
La Merie Publishing
March 2013
Price: USD 1,203.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
颁补迟补濒辞驳:听
CBR Pharma Insights
July 2015
Price: USD 2,995.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
颁补迟补濒辞驳:听
La Merie Publishing
June 2022
Price: USD 1,170.00
听
